Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Identification of predictive biomarkers for severe acute leptospirosis and its long-term sequelae

Award Number: R01AI183353
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/09/2024
PERIOD OF PERFORMANCE END DATE: 07/31/2029

Group Awards By:

View Award Description

Identification of predictive biomarkers for severe acute leptospirosis and its long-term sequelae - Leptospirosis is a potentially life-threatening zoonosis with protean manifestations and a leading cause of acute febrile illness (AFI) in the tropics. The acute phase of leptospirosis can trigger a systemic inflammatory response, leading to multiorgan failure, including liver failure, acute kidney injury (AKI), and pulmonary hemorrhage, significantly increasing mortality, and potentially resulting in long-term complications. Early prediction of severe disease progression and long-term consequences is of utmost importance. The proposed studies will involve collaborations between the Principal Investigator and renowned researchers in the field of leptospirosis. We have outlined two related but independent aims. Aim 1 focuses on characterizing the host response and identifying novel biomarkers predictive of severe acute leptospirosis using a multi-omics approach. We will analyze blood specimens and clinical data from our existing biorepository and prospective patient recruitment, employing established and novel machine learning analytical methods to refine proteomic, cytokine-based, and host gene expression severity classifiers, accurately identifying patients at risk of severe disease. Our existing biorepository contains samples collected at baseline from 218 patients with confirmed leptospirosis, including 73 severe cases and 145 non-severe cases. Longitudinal follow-up clinical data and blood specimens per patient are also available, enabling us to study the temporal dynamics of the host response and disease progression. Aim 2 focuses on identifying risk factors and novel biomarkers for leptospiral CKD and its progression. We have been concurrently conducting a prospective multicenter cohort study and a clinical trial titled Leptospirosis Care Bundle Study across several hospitals in endemic areas. We have, and will continue to collect long-term follow-up data on adverse outcomes, including major kidney adverse events (MAKEs), such as all-cause mortality, dialysis, and new-onset CKD in patients with leptospirosis at baseline. Combining data from these two ongoing projects, totaling 160 patients, will provide us with a better understanding of the mechanisms and risk factors associated with leptospiral CKD.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $137,229 )
2025	2025	CHULALONGKORN UNIVERSITY	254 PHAYATHAI ROAD PATHUM WAN	BANGKOK				THA	Allergy and Infectious Diseases Research	000	2	8/12/2025	NON-COMPETING CONTINUATION	$137,229
														Subtotal = $137,229

Issue Date FY: 2024 ( Subtotal = $137,229 )
2024	2024	CHULALONGKORN UNIVERSITY	254 PHAYATHAI ROAD PATHUM WAN	BANGKOK				THA	Allergy and Infectious Diseases Research	000	1	8/9/2024	NEW	$137,229
														Subtotal = $137,229

Grand Total All Awards = $274,458

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Identification of predictive biomarkers for severe acute leptospirosis and its long-term sequelae

Award Number: R01AI183353

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/09/2024

PERIOD OF PERFORMANCE END DATE: 07/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer